Lung Cancer | Tumor

Obesity May Be Associated with Increased Cancer Mortality in Most Cancers; Lower in Others

April 14th 2021, 6:00pm


Recent study results demonstrated an possible association between a high BMI and risk of cancer and overall mortality, though patients with obesity and lung cancer, renal cell carcinoma and melanoma were found to have a lower risk of death than patients with the same cancers without obesity.

Webinar Recap: Know Your Lung Cancer: Accelerating Education and Access for Biomarker Testing

April 13th 2021, 6:00pm


On Feb. 18, CURE hosted a webinar focused on educating patients on biomarker testing. Here, we highlight key takeaways from our panelists.

CURE®'s Educated Patient® Lung Cancer Summit At a Glance

April 10th 2021, 3:00pm


Take a look back at CURE®’s Educated Patient® Lung Cancer Summit with this roundup of stories that highlight what was discussed at this half-day virtual event.

Addressing Aspects Outside of Treatment, Looking Ahead in Lung Cancer Care

April 7th 2021, 12:00pm


CURE spoke with the LUNGevity Foundation about lung cancer and its treatments, as well as aspects to cancer outside of day-to-day care.

CURE’s Top Stories: March 2021

April 1st 2021, 1:00pm


Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for March 2021.

Newly-Approved Lorbrena Shows Better Responses in Patients With Brain Metastases

March 31st 2021, 6:00pm


The FDA recently approved an expanded indication for Lorbrena as a first-line treatment option for a subset of lung cancer that has spread to the brain. Compared to previously-approved options, experts say Lorbrena is more effective.

Opdivo With or Without Yervoy Did Not Prolong Survival in Small Cell Lung Cancer

March 29th 2021, 9:00pm


Previously, treatments for patients with extensive-disease small cell lung cancer were limited with a poor prognosis. Researchers sought to investigate if Opdivo plus Yervoy or Opdivo alone would improve survival.

CURE’s Clinical Trial Corner: March 2021

March 25th 2021, 1:00pm


Here is a list of some recent trials that launched within the cancer space in March.

FDA Fast Track of Novel Drug May Open Doors for Certain Patients with Non-Small Cell Lung Cancer

March 15th 2021, 3:00pm


The FDA’s fast track designation to poziotinib for use in previously treated patients with non-small cell lung cancer whose disease harbors a certain genetic mutation, may open the doors to an accelerated approval.

The Future of Adoptive Cellular Therapy in Lung Cancer

March 15th 2021, 1:00pm


In the field of lung cancer, a number of current studies evaluating the efficacy of adoptive cellular therapies may one day offer patients with non-small cell lung cancer a “high risk, high reward” treatment option, according to Dr. Ben Creelan of the Moffitt Cancer Center.